Table 4.
Demographic, biochemical, and clinical characteristics of <65 and ≥65 yr old obese subjects (non-older and older subjects, respectively), recruited in the study, subdivided into the two groups with or without metabolic syndrome, who underwent the 3-week BWRP.
| <65 yr old Obese Subjects | ||||
| Parameter | Without Metabolic Syndrome | With Metabolic Syndrome | ||
| Before | After | Before | After | |
| N. | 630 | - | 964 | - |
| Age (yr) | 42.4 ± 12.9 a | - | 49.5 ± 10.8 | - |
| BMI (kg/m2) | 42.6 ± 5.3 a | 40.7 ± 5.1 b | 44.2 ± 6.8 | 42.2 ± 6.5 b |
| TOT-CHOL (mg/dL) | 190.5 ± 35.6 a | 167.8 ± 31.0 b | 197.9 ± 38.0 | 170.9 ± 34.7 b |
| HDL-CHOL (mg/dL) | 55.1 ± 12.4 a | 46.2 ± 10.5 b | 45.1 ± 11.2 | 39.5 ± 9.2 b |
| DBP (mmHg) | 75.9 ± 7.7 a | 73.7 ± 6.5 b | 77.7 ± 7.6 | 74.8 ± 6.6 b |
| SBP (mmHg) | 124.0 ± 12.5 a | 119.4 ± 8.8 b | 129.9 ± 13.3 | 121.7 ± 9.4 b |
| CHD score | 2.3 ± 5.4 a | 2.5 ± 5.6 | 7.8 ± 5.0 | 7.1 ± 5.3 b |
| FSS | 33.2 ± 12.2 a | 25.4 ± 10.6 b | 37.4 ± 12.3 | 28.6 ± 11.2 b |
| SCT (s) | 5.5 ± 1.6 a | 5.2 ± 1.5 b | 6.2 ± 1.8 | 5.8 ± 1.7 b |
| ≥65 yr old Obese Subjects | ||||
| Parameter | Without Metabolic Syndrome | With Metabolic Syndrome | ||
| Before | After | Before | After | |
| N. | 96 | - | 232 | - |
| Age (yr) | 70.3 ± 4.1 | - | 69.5 ± 3.9 | - |
| BMI (kg/m2) | 42.0 ± 5.5 | 40.3 ± 5.3 b | 42.4 ± 5.7 | 40.8 ± 5.5 b |
| TOT-CHOL (mg/dL) | 196.2 ± 34.4 | 169.3 ± 31.8 b | 198.3 ± 37.8 | 168.0 ± 36.3 b |
| HDL-CHOL (mg/dL) | 61.8 ± 9.3 a | 49.1 ± 9.4 b | 47.9 ± 11.7 | 40.9 ± 9.8 b |
| DBP (mmHg) | 77.9 ± 9.0 | 74.6 ± 6.0 b | 77.2 ± 8.2 | 74.6 ± 6.6 b |
| SBP (mmHg) | 135.1 ± 17.8 | 123.6 ± 9.6b | 132.6 ± 14.6 | 124.4 ± 10.4 b |
| CHD score | 7.6 ± 2.4 a | 7.8 ± 2.6 | 10.9 ± 3.1 | 10.6 ± 3.3 |
| FSS | 43.4 ± 12.7 | 36.8 ± 12.7 b | 41.7 ± 13.5 | 35.0 ± 12.9 b |
| SCT (s) | 7.9 ± 2.1 | 7.6 ± 2.0 b | 7.7 ± 2.0 | 7.4 ± 1.9 b |
Abbreviations: BMI, body mass index; TOT-CHOL, total cholesterol; HDL-chol, high-density lipoprotein cholesterol; DBP, diastolic blood pressure; SBP, systolic blood pressure; CHD, coronary heart disease; FSS, fatigue severity score; SCT, stair climbing test. a: p < 0.05 vs. group with metabolic syndrome; b: p < 0.05 vs. the corresponding group before BWRP.